Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × pCR Rate × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 8 Polycystic Ovary Syndrome 7 Carcinoma, Non-Small-Cell Lung 6 Colorectal Neoplasms 5 Breast Neoplasms 5 Lung Neoplasms 4 Metabolic Syndrome 3 Insulin Resistance 3 Adenocarcinoma of Lung 3 Lymphoma, Large B-Cell, Diffuse 2 Glioblastoma 2 Carcinoma, Renal Cell 2 pCR Rate 1 Weight Gain 1 Thyroid Diseases 1 Thoracic Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Motor Activity 1 Melanoma 1 Lymphoma 1 Leukoplakia 1 Leukemia, Myelomonocytic, Acute 1

Interventions

Metformin 1 Epirubicin 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01929811 2022-04-06

NeoMET

Shanghai Jiao Tong University School of Medicine

Phase 2 Terminated

pCR Rate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡